Skip to main content
Premium Trial:

Request an Annual Quote

EMBL Becomes Customer of Amersham s CodeLink Microarray Platform

This update serves to clarify that Amersham has not sold its CodeLink business to EMBL, but rather a CodeLink system for internal research.


NEW YORK, Jan. 21 (GenomeWeb News) - Amersham Biosciences has sold a CodeLink microarray platform to the European Molecular Biology Laboratory, Amersham said today.


EMBL's genomics core facility in Heidelberg will offer gene-expression services based on the technology to EMBL groups and their collaborators. In addition, EMBL and Amersham will jointly organize training and access to the platform. An EMBL developmental biology research groups has already been using CodeLink microarrays to study gene expression in mice, according to Amersham.


According to the EMBL website, its core facility is also offering services using Affymetrix's gene expression platform.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.